Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process
- DOI
- 10.1186/s12879-026-13389-1
- Published
- 2026-05-09
- Container
- BMC Infectious Diseases
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12879-026-13389-1,
title = {Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process},
author = {Hyeontaek Hwang and Jung Eun Shin and Soonryu Seo and Su Jin Hong and Mi Ri Jang and Hyungseok Kang and Jeongha Mok and Yong-Soo Kwon and Doosoo Jeon and Tae Sun Shim and Jae-Joon Yim},
year = {2026},
journal = {BMC Infectious Diseases},
doi = {10.1186/s12879-026-13389-1},
url = {https://doi.org/10.1186/s12879-026-13389-1}
}RIS
TY - JOUR TI - Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process AU - Hyeontaek Hwang AU - Jung Eun Shin AU - Soonryu Seo AU - Su Jin Hong AU - Mi Ri Jang AU - Hyungseok Kang AU - Jeongha Mok AU - Yong-Soo Kwon AU - Doosoo Jeon AU - Tae Sun Shim AU - Jae-Joon Yim PY - 2026 JO - BMC Infectious Diseases DO - 10.1186/s12879-026-13389-1 UR - https://doi.org/10.1186/s12879-026-13389-1 ER -
APA
Hwang, H., Shin, J. E., Seo, S., Hong, S. J., Jang, M. R., Kang, H., Mok, J., Kwon, Y., Jeon, D., Shim, T. S., & Yim, J. (2026). Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-13389-1
Source records
- crossref · retrieved 2026-09-26T21:52:27.251Z